Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (Q4)Dec 31, 2019 | (Q3)Sep 30, 2019 | (Q2)Jun 30, 2019 | (Q1)Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.66B | 16.91%595.79M | 13.56%509.63M | 7.42%448.76M | 18.51%417.75M | 7.76%352.49M | 14.25%106.16M | 0.96%86.99M | 9.36%80.89M | 5.93%78.46M |
| Cost of revenue | 1.55B | 20.37%555.46M | 9.18%461.48M | 13.04%422.68M | 24.38%373.92M | 8.26%300.62M | 15.52%92.95M | 0.02%73.76M | 8.24%65.78M | 8.67%68.13M |
| Gross profit | 104.26M | -16.26%40.32M | 84.56%48.15M | -40.48%26.09M | -15.50%43.83M | 4.92%51.87M | 6.04%13.21M | 6.50%13.22M | 14.52%15.11M | -9.19%10.33M |
| Operating expense | 30.59M | -5.72%20.16M | 31.00%21.39M | 12.64%16.33M | -12.34%14.49M | 16.91%16.53M | 7.46%4.93M | 42.33%4.44M | -0.35%3.73M | 27.51%3.44M |
| Selling and administrative expenses | --28.38M | -5.72%20.16M | 31.00%21.39M | 12.64%16.33M | -12.34%14.49M | 16.91%16.53M | 7.46%4.93M | 42.33%4.44M | -0.35%3.73M | 27.51%3.44M |
| -Selling and marketing expense | --13.38M | -17.84%7.12M | 64.38%8.66M | 18.80%5.27M | -32.89%4.44M | 17.95%6.61M | 54.77%2.24M | 19.48%1.74M | -2.30%1.4M | -3.01%1.23M |
| -General and administrative expense | --15M | 2.53%13.05M | 15.09%12.72M | 9.92%11.06M | 1.34%10.06M | 16.22%9.93M | -14.38%2.69M | 62.36%2.7M | 0.87%2.33M | 54.44%2.21M |
| Depreciation and amortization | --1.97M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Depreciation | --1.09M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Amortization | --877K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Rent and land expenses | --250K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 73.67M | -24.67%20.16M | 174.14%26.76M | -66.72%9.76M | -16.97%29.34M | 0.11%35.34M | 5.21%8.28M | -5.53%8.78M | 20.41%11.38M | -20.57%6.9M |
| Net non-operating interest income expense | -37.27M | -133.22%-15.3M | -82.35%-6.56M | 24.73%-3.6M | 5.61%-4.78M | -99.17%-5.06M | -117.88%-1.65M | -154.48%-1.34M | -59.82%-1.08M | -71.11%-1M |
| Non-operating interest income | --260K | 53.64%169K | 19.57%110K | -29.77%92K | 47.19%131K | -19.09%89K | -3.03%32K | -54.55%15K | 40.00%21K | -27.59%21K |
| Non-operating interest expense | --35.07M | 131.91%15.47M | 80.78%6.67M | -24.87%3.69M | -4.70%4.91M | 94.27%5.15M | 112.82%1.68M | 142.11%1.35M | 59.39%1.1M | 66.45%1.02M |
| Total other finance cost | --2.46M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | -883K | |||||||||
| Gain/Loss on financial instruments designated as cash flow hedges | -3.58M | |||||||||
| Gain/Loss on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income /charges | -45K | |||||||||
| Less:Impairment of capital assets | --5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | --40K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income /expenses | -178K | -268.03%-3.41M | -107.60%-926K | 684.74%12.19M | -246.97%-2.08M | 6.46%1.42M | -19.36%1.43M | -110.32%-42K | -106.27%-90K | 105.30%121K |
| Income before tax | 31.72M | -92.45%1.46M | 5.05%19.28M | -18.35%18.35M | -29.08%22.48M | -7.03%31.69M | -9.26%8.06M | -19.33%7.4M | -0.02%10.21M | 3.47%6.02M |
| Income tax | 8.59M | -116.96%-440K | -42.36%2.6M | 46.60%4.5M | -43.86%3.07M | -25.10%5.47M | -79.09%911K | 673.25%1.76M | 11.29%1.8M | -9.74%991K |
| Net income | 23.13M | -88.64%1.9M | 20.46%16.68M | -28.63%13.85M | -26.00%19.41M | -2.10%26.22M | 57.88%7.15M | -36.97%5.64M | -2.15%8.4M | 6.55%5.03M |
| Net income continuous operations | --23.13M | -88.64%1.9M | 20.46%16.68M | -28.63%13.85M | -26.00%19.41M | -2.10%26.22M | 57.88%7.15M | -36.97%5.64M | -2.15%8.4M | 6.55%5.03M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 23.13M | -88.64%1.9M | 20.46%16.68M | -28.63%13.85M | -26.00%19.41M | -2.10%26.22M | 57.88%7.15M | -36.97%5.64M | -2.15%8.4M | 6.55%5.03M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 23.13M | -88.64%1.9M | 20.46%16.68M | -28.63%13.85M | -26.00%19.41M | -2.10%26.22M | 57.88%7.15M | -36.97%5.64M | -2.15%8.4M | 6.55%5.03M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 0.0758 | -89.09%0.006 | 19.57%0.0549 | -28.12%0.0459 | -25.58%0.0638 | -5.50%0.0858 | 61.54%0.023 | -36.95%0.0185 | 0.00%0.0279 | 6.41%0.0166 |
| Diluted earnings per share | 0.0758 | -89.09%0.006 | 19.57%0.0549 | -28.12%0.0459 | -25.58%0.0638 | -5.50%0.0858 | 61.54%0.023 | -36.95%0.0185 | 0.00%0.0279 | 6.41%0.0166 |
| Dividend per share | 22.22%0.0133 | -14.82%0.0109 | -23.71%0.0128 | -23.36%0.0167 | 7.75%0.0218 | 0 | -1.44%0.0072 | 0.0146 | 0 | |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |